Polymers and nanomedicine: Considerations on variability and reproducibility when combining complex systems

Nanomedicine

Volumn 10, Issue 20, 2015, Pages 3109-3119

  Luxenhofer, Robert ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

biocompatibility; biomaterials; dispersity; reproducibility

Indexed keywords

COPOLYMER; GLATIRAMER; POLYMER; BIOMATERIAL;

ARTICLE; BIOCOMPATIBILITY; BIOMEDICINE; BIOSYNTHESIS; HIGH THROUGHPUT SCREENING; HUMAN; NANOMEDICINE; NATURAL SCIENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; CHEMISTRY; PROCEDURES;

BIOCOMPATIBLE MATERIALS; NANOMEDICINE; POLYMERS;

EID: 84944234214     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.139     Document Type: Article

References (49)

1. Popper K. Conjectures and Refutations: The Growth of Scientific Knowledge. Routledge, London, UK (1936).
2. Jasny BR, Chin G, Chong L, Vignieri S. Again, and again, and again .... Science 334(6060), 1225 (2011).
3. Grant B. The Scientist. www.the-scientist.com/?articles.view/
4. Casadevall A, Fang FC. Reproducible science. Infect. Immun. 78(12), 4972-4975 (2010).
5. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10(9), 712-712 (2011).
6. Begley CG, Ellis LM. Raise standards for preclinical cancer research. Nature 483, 531-533 (2012).
7. Landis SC, Amara SG, Asadullah K et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490(7419), 187-191 (2012).
8. Bissell M. Reproducibility: the risks of the replication drive. Nat. News 503(7476), 333 (2013).
9. Kraus WL. Do you see what I see? Quality, reliability, and reproducibility in biomedical research. Mol. Endocrinol. 28(3), 277-280 (2014).
10. Peng RD. Reproducible research in computational science. Science 334(6060), 1226-1227 (2011).
11. Pashler H, Harris CR. Is the replicability crisis overblown? Three arguments examined. Perspect. Psychol. Sci. 7(6), 531-536 (2012).
12. Ozin G. Nanochemistry reproducibility. www.materialsviews.com/nanochemistry-reproducibility/
13. Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 13(6), e1002165 (2015).
14. Drummond C. Replicability is not reproducibility: nor is it good science. Presented at: Proceedings of the Evaluation Methods for Machine Learning, Workshop 26th International Conference for Machine Learning. Quebec, Canada, 14-18 June 2009.
15. Stern AM, Casadevall A, Steen RG, Fang FC. Financial costs and personal consequences of research misconduct resulting in retracted publications. eLife 3, e02956 (2014).
16. Adiseshaiah PP, Hall JB, McNeil SE. Nanomaterial standards for efficacy and toxicity assessment. WIREs Nanomed. Nanobiotechnol. 2(1), 99-112 (2010).
17. Crist RM, Grossman JH, Patri AK et al. Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory. Integr. Biol. (Camb.) 5(1), 66-73 (2013).
18. Dobrovolskaia MA, Patri AK, Simak J et al. Nanoparticle size and surface charge determine effects on PAMAM dendrimers on human platelets in vitro. Nanomedicine (Lond.) 9(3), 382-393 (2012).
19. Fetsch C, Luxenhofer R. Highly defined multiblock copolypeptoids: pushing the limits of living nucleophilic ring-opening polymerization. Macromol. Rapid Commun. 33(19), 1708-1713 (2012).
20. Stepto RFT. Dispersity in polymer science (IUPAC Recommendation 2009). Polym. Int. 59(1), 23-24 (2010).
21. Jenkins AD, Jones RG, Moad G. Terminology for reversibledeactivation radical polymerization previously called "controlled" radical or "living" radical polymerization (IUPAC recommendations 2010). Pure Appl. Chem. 82(2), 483-491 (2010).
22. Kawamura K. The structure of multivariate Poisson distribution. Kodai Math. J. 2(3), 337-345 (1979).
23. Loukas S, Papageorgiou H. On a trivariate Poisson distribution. Applications Mathematics 36(6), 432-439 (1991).
24. Karlis D, Ntzoufras I. Bivariate Poisson and diagonal inflated bivariate Poisson regression models in R. J. Stat. Soft 14(10), 6303123 (2005).
25. Hasson T. The complexity of Copaxone® and life cycle management. Presented at: 10th International Symposium on Polymer Therapeutics. Valencia, Spain, 20 May 2014.
26. Towfic F, Funt JM, Fowler KD et al. Comparing the biological impact of glatiramer acetate with the biological impact of a generic. PLoS ONE 9(1), e83757 (2014).
27. Kolitz S, Hasson T, Towfic F et al. Gene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoids. Sci. Rep. 5, 10191 (2015).
28. Mobley A, Linder SK, Braeuer R, Ellis LM, Zwelling L. A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic. PLoS ONE 8(5), e63221 (2013).
29. Latour B, Woolgar S. Laboratory Life: The Construction of Scientific Facts. Princeton University Press, NJ, USA (1986).
30. Oreskes N, Conway EM. Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming. Bloomsbury Publishing, NY, USA (2010).
31. Oreskes N, Conway EM. Defeating the merchants of doubt. Nature 465(7299), 686-687 (2010).
32. The Economist. www.economist.com/news/leaders
33. The New York Times. www.nytimes.com/2014/01/21/science
34. Die Zeit, Bitte nur die ganze Wahrheit! www.zeit.de/2014/31/betrug-wissenschaft
35. Schillmeier M. Caring for complexity in nanomedicine. Nanomedicine (Lond.) 10(20), 3181-3193 (2015).
36. Frahn J, Karakaya B, Schäfer A, Schlüter A. Suzuki polycondensation: on catalyst derived phosphorus incorporation and reproducibility of molecular weights. Tetrahedron 53(45), 15459-15467 (1997).
37. Hoogenboom R, Meier MAR, Schubert US. Combinatorial methods, automated synthesis and high-throughput screening in polymer research: past and present. Macromol. Rapid Commun. 24(1), 15-32 (2003).
38. Fijten MWM, Meier MAR, Hoogenboom R, Schubert US. Automated parallel investigations/optimizations of the reversible addition-fragmentation chain transfer polymerization of methyl methacrylate. J. Polym. Sci. A Polym. Chem. 42(22), 5775-5783 (2004).
39. Luxenhofer R, Schulz A, Roques C et al. Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials 31(18), 4972-4979 (2010).
40. Han Y, He Z, Schulz A et al. Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles. Mol. Pharm. 9(8), 2302-2313 (2012).
41. Schulz A, Jaksch S, Schubel R et al. Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s. ACS Nano 8(3), 2686-2696 (2014).
42. He Z, Schulz A, Wan X et al. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation. J. Control. Release 208, 67-75 (2015).
43. Seo Y, Schulz A, Han Z et al. Poly(2-oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration and environmental factors. Polym. Advan. Technol. 26, 837-850 (2015).
44. Kalyanasundaram K, Thomas JK. Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J. Am. Chem. Soc. 99(7), 2039-2044 (1977).
45. Langer K, Anhorn MG, Steinhauser I et al. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int. J. Pharm. 347(1-2), 109-117 (2008).
46. Cipitria A, Skelton A, Dargaville TR, Dalton PD, Hutmacher DW. Design, fabrication and characterization of PCL electrospun scaffolds-a review. J. Mater. Chem. 21(26), 9419 (2011).
47. Siegwart DJ, Whitehead KA, Nuhn L et al. Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery. Proc. Natl Acad. Sci. USA 108(32), 12996-13001 (2011).
48. Popper K. The Logic of Scientific Discovery. Hutchinson, London, UK (1959).
49. Wikipedia. http://en.wikipedia.org/wiki/Reproducibility